ASCO GUIDELINES Bundle

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475475

Contents of this Issue

Navigation

Page 8 of 9

9 May be followed closely with serial cross-sectional imaging or PET/CT, with neck dissection reserved for clinical or radiographic concern for progressive disease Neck Dissection PET/CT scan at ≥12 weeks after completion of radiation/chemoradiation Intense FDG uptake in any node No nodal FDG uptake and no abnormally enlarged lymph nodes Mild FDG in a node ≤1 cm or a persistently enlarged node ≥1 cm without either mild or intense FDG uptake No Neck Dissection Patients who complete radiation/ chemoradiation and have anatomic cross-sectional imaging (CT or MRI scans) at ≥12 weeks post therapy showing resolution of previously abnormal lymph nodes

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx